Schering-Plough, is to launch Zylkene, a new product to help manage stress in cats and dogs at BSAVA Congress this April.

Zylkene is a globally patented bioactive decapeptide derived from the milk protein casein. The company says that it will provide cat and dog owners with a proven alternative to managing stress in their pets and help to manage many common behavioural problems.

Zylkene will be available in 75mg, 225mg and 450mg capsules, which can be given whole or opened and mixed with food or a treat. The initial period of use is 1-2 months, and can be repeated if necessary.

For further information, please contact your local Schering-Plough or Intervet representative on 01895 626 000.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.